The global market for Varicella Virus (Chickenpox) Vaccine was valued at US$ 2916 million in the year 2024 and is projected to reach a revised size of US$ 5388 million by 2031, growing at a CAGR of 9.3% during the forecast period.

Varicella Virus (Chickenpox) Vaccine Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Varicella Virus (Chickenpox) Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Varicella Virus (Chickenpox) Vaccine.

The Varicella Virus (Chickenpox) Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Varicella Virus (Chickenpox) Vaccine market comprehensively. Regional market sizes, concerning products by Type, by User, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Varicella Virus (Chickenpox) Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by User, and by regions.

Scope of Varicella Virus (Chickenpox) Vaccine Market Report

Report Metric	Details
Report Name	Varicella Virus (Chickenpox) Vaccine Market
Accounted market size in year	US$ 2916 million
Forecasted market size in 2031	US$ 5388 million
CAGR	9.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Monovalent Vaccine Combination Vaccine
Segment by User	Children Teenagers Adults
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	GSK, Merck & Co., Sanofi Pasteur, Green Cross, Shanghai Institute, BCHT, Changsheng, Keygen, Biken
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Varicella Virus (Chickenpox) Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Varicella Virus (Chickenpox) Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Varicella Virus (Chickenpox) Vaccine Market growing?

Ans: The Varicella Virus (Chickenpox) Vaccine Market witnessing a CAGR of 9.3% during the forecast period 2025-2031.

What is the Varicella Virus (Chickenpox) Vaccine Market size in 2031?

Ans: The Varicella Virus (Chickenpox) Vaccine Market size in 2031 will be US$ 5388 million.

Who are the main players in the Varicella Virus (Chickenpox) Vaccine Market report?

Ans: The main players in the Varicella Virus (Chickenpox) Vaccine Market are GSK, Merck & Co., Sanofi Pasteur, Green Cross, Shanghai Institute, BCHT, Changsheng, Keygen, Biken

What are the Type segmentation covered in the Varicella Virus (Chickenpox) Vaccine Market report?

Ans: The Types covered in the Varicella Virus (Chickenpox) Vaccine Market report are Monovalent Vaccine, Combination Vaccine

1 Varicella Virus (Chickenpox) Vaccine Market Overview

1.1 Product Definition

1.2 Varicella Virus (Chickenpox) Vaccine by Type

1.2.1 Global Varicella Virus (Chickenpox) Vaccine Market Value Comparison by Type (2024 VS 2031)

1.2.2 Monovalent Vaccine

1.2.3 Combination Vaccine

1.3 Varicella Virus (Chickenpox) Vaccine by User

1.3.1 Global Varicella Virus (Chickenpox) Vaccine Market Value by User (2024 VS 2031)

1.3.2 Children

1.3.3 Teenagers

1.3.4 Adults

1.4 Global Varicella Virus (Chickenpox) Vaccine Market Size Estimates and Forecasts

1.4.1 Global Varicella Virus (Chickenpox) Vaccine Revenue 2020-2031

1.4.2 Global Varicella Virus (Chickenpox) Vaccine Sales 2020-2031

1.4.3 Global Varicella Virus (Chickenpox) Vaccine Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Varicella Virus (Chickenpox) Vaccine Market Competition by Manufacturers

2.1 Global Varicella Virus (Chickenpox) Vaccine Sales Market Share by Manufacturers (2020-2025)

2.2 Global Varicella Virus (Chickenpox) Vaccine Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Varicella Virus (Chickenpox) Vaccine Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Varicella Virus (Chickenpox) Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Varicella Virus (Chickenpox) Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Varicella Virus (Chickenpox) Vaccine, Product Type & Application

2.7 Global Key Manufacturers of Varicella Virus (Chickenpox) Vaccine, Date of Enter into This Industry

2.8 Global Varicella Virus (Chickenpox) Vaccine Market Competitive Situation and Trends

2.8.1 Global Varicella Virus (Chickenpox) Vaccine Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Varicella Virus (Chickenpox) Vaccine Players Market Share by Revenue

2.8.3 Global Varicella Virus (Chickenpox) Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Varicella Virus (Chickenpox) Vaccine Market Scenario by Region

3.1 Global Varicella Virus (Chickenpox) Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Varicella Virus (Chickenpox) Vaccine Sales by Region: 2020-2031

3.2.1 Global Varicella Virus (Chickenpox) Vaccine Sales by Region: 2020-2025

3.2.2 Global Varicella Virus (Chickenpox) Vaccine Sales by Region: 2026-2031

3.3 Global Varicella Virus (Chickenpox) Vaccine Revenue by Region: 2020-2031

3.3.1 Global Varicella Virus (Chickenpox) Vaccine Revenue by Region: 2020-2025

3.3.2 Global Varicella Virus (Chickenpox) Vaccine Revenue by Region: 2026-2031

3.4 North America Varicella Virus (Chickenpox) Vaccine Market Facts & Figures by Country

3.4.1 North America Varicella Virus (Chickenpox) Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Varicella Virus (Chickenpox) Vaccine Sales by Country (2020-2031)

3.4.3 North America Varicella Virus (Chickenpox) Vaccine Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Varicella Virus (Chickenpox) Vaccine Market Facts & Figures by Country

3.5.1 Europe Varicella Virus (Chickenpox) Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Varicella Virus (Chickenpox) Vaccine Sales by Country (2020-2031)

3.5.3 Europe Varicella Virus (Chickenpox) Vaccine Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Varicella Virus (Chickenpox) Vaccine Market Facts & Figures by Region

3.6.1 Asia Pacific Varicella Virus (Chickenpox) Vaccine Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Varicella Virus (Chickenpox) Vaccine Sales by Region (2020-2031)

3.6.3 Asia Pacific Varicella Virus (Chickenpox) Vaccine Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Varicella Virus (Chickenpox) Vaccine Market Facts & Figures by Country

3.7.1 Latin America Varicella Virus (Chickenpox) Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Varicella Virus (Chickenpox) Vaccine Sales by Country (2020-2031)

3.7.3 Latin America Varicella Virus (Chickenpox) Vaccine Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Varicella Virus (Chickenpox) Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Varicella Virus (Chickenpox) Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Varicella Virus (Chickenpox) Vaccine Sales by Country (2020-2031)

3.8.3 Middle East and Africa Varicella Virus (Chickenpox) Vaccine Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Varicella Virus (Chickenpox) Vaccine Sales by Type (2020-2031)

4.1.1 Global Varicella Virus (Chickenpox) Vaccine Sales by Type (2020-2025)

4.1.2 Global Varicella Virus (Chickenpox) Vaccine Sales by Type (2026-2031)

4.1.3 Global Varicella Virus (Chickenpox) Vaccine Sales Market Share by Type (2020-2031)

4.2 Global Varicella Virus (Chickenpox) Vaccine Revenue by Type (2020-2031)

4.2.1 Global Varicella Virus (Chickenpox) Vaccine Revenue by Type (2020-2025)

4.2.2 Global Varicella Virus (Chickenpox) Vaccine Revenue by Type (2026-2031)

4.2.3 Global Varicella Virus (Chickenpox) Vaccine Revenue Market Share by Type (2020-2031)

4.3 Global Varicella Virus (Chickenpox) Vaccine Price by Type (2020-2031)

5 Segment by User

5.1 Global Varicella Virus (Chickenpox) Vaccine Sales by User (2020-2031)

5.1.1 Global Varicella Virus (Chickenpox) Vaccine Sales by User (2020-2025)

5.1.2 Global Varicella Virus (Chickenpox) Vaccine Sales by User (2026-2031)

5.1.3 Global Varicella Virus (Chickenpox) Vaccine Sales Market Share by User (2020-2031)

5.2 Global Varicella Virus (Chickenpox) Vaccine Revenue by User (2020-2031)

5.2.1 Global Varicella Virus (Chickenpox) Vaccine Revenue by User (2020-2025)

5.2.2 Global Varicella Virus (Chickenpox) Vaccine Revenue by User (2026-2031)

5.2.3 Global Varicella Virus (Chickenpox) Vaccine Revenue Market Share by User (2020-2031)

5.3 Global Varicella Virus (Chickenpox) Vaccine Price by User (2020-2031)

6 Key Companies Profiled

6.1 GSK

6.1.1 GSK Company Information

6.1.2 GSK Description and Business Overview

6.1.3 GSK Varicella Virus (Chickenpox) Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.1.4 GSK Varicella Virus (Chickenpox) Vaccine Product Portfolio

6.1.5 GSK Recent Developments/Updates

6.2 Merck & Co.

6.2.1 Merck & Co. Company Information

6.2.2 Merck & Co. Description and Business Overview

6.2.3 Merck & Co. Varicella Virus (Chickenpox) Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Merck & Co. Varicella Virus (Chickenpox) Vaccine Product Portfolio

6.2.5 Merck & Co. Recent Developments/Updates

6.3 Sanofi Pasteur

6.3.1 Sanofi Pasteur Company Information

6.3.2 Sanofi Pasteur Description and Business Overview

6.3.3 Sanofi Pasteur Varicella Virus (Chickenpox) Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Sanofi Pasteur Varicella Virus (Chickenpox) Vaccine Product Portfolio

6.3.5 Sanofi Pasteur Recent Developments/Updates

6.4 Green Cross

6.4.1 Green Cross Company Information

6.4.2 Green Cross Description and Business Overview

6.4.3 Green Cross Varicella Virus (Chickenpox) Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Green Cross Varicella Virus (Chickenpox) Vaccine Product Portfolio

6.4.5 Green Cross Recent Developments/Updates

6.5 Shanghai Institute

6.5.1 Shanghai Institute Company Information

6.5.2 Shanghai Institute Description and Business Overview

6.5.3 Shanghai Institute Varicella Virus (Chickenpox) Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Shanghai Institute Varicella Virus (Chickenpox) Vaccine Product Portfolio

6.5.5 Shanghai Institute Recent Developments/Updates

6.6 BCHT

6.6.1 BCHT Company Information

6.6.2 BCHT Description and Business Overview

6.6.3 BCHT Varicella Virus (Chickenpox) Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.6.4 BCHT Varicella Virus (Chickenpox) Vaccine Product Portfolio

6.6.5 BCHT Recent Developments/Updates

6.7 Changsheng

6.7.1 Changsheng Company Information

6.7.2 Changsheng Description and Business Overview

6.7.3 Changsheng Varicella Virus (Chickenpox) Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Changsheng Varicella Virus (Chickenpox) Vaccine Product Portfolio

6.7.5 Changsheng Recent Developments/Updates

6.8 Keygen

6.8.1 Keygen Company Information

6.8.2 Keygen Description and Business Overview

6.8.3 Keygen Varicella Virus (Chickenpox) Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Keygen Varicella Virus (Chickenpox) Vaccine Product Portfolio

6.8.5 Keygen Recent Developments/Updates

6.9 Biken

6.9.1 Biken Company Information

6.9.2 Biken Description and Business Overview

6.9.3 Biken Varicella Virus (Chickenpox) Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Biken Varicella Virus (Chickenpox) Vaccine Product Portfolio

6.9.5 Biken Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Varicella Virus (Chickenpox) Vaccine Industry Chain Analysis

7.2 Varicella Virus (Chickenpox) Vaccine Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Varicella Virus (Chickenpox) Vaccine Production Mode & Process Analysis

7.4 Varicella Virus (Chickenpox) Vaccine Sales and Marketing

7.4.1 Varicella Virus (Chickenpox) Vaccine Sales Channels

7.4.2 Varicella Virus (Chickenpox) Vaccine Distributors

7.5 Varicella Virus (Chickenpox) Vaccine Customer Analysis

8 Varicella Virus (Chickenpox) Vaccine Market Dynamics

8.1 Varicella Virus (Chickenpox) Vaccine Industry Trends

8.2 Varicella Virus (Chickenpox) Vaccine Market Drivers

8.3 Varicella Virus (Chickenpox) Vaccine Market Challenges

8.4 Varicella Virus (Chickenpox) Vaccine Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Varicella Virus (Chickenpox) Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Varicella Virus (Chickenpox) Vaccine Market Value by User (2024 VS 2031) & (US$ Million)

Table 3. Global Varicella Virus (Chickenpox) Vaccine Market Competitive Situation by Manufacturers in 2024

Table 4. Global Varicella Virus (Chickenpox) Vaccine Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Varicella Virus (Chickenpox) Vaccine Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Varicella Virus (Chickenpox) Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Varicella Virus (Chickenpox) Vaccine Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Varicella Virus (Chickenpox) Vaccine Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Varicella Virus (Chickenpox) Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Varicella Virus (Chickenpox) Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Varicella Virus (Chickenpox) Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of Varicella Virus (Chickenpox) Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Varicella Virus (Chickenpox) Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Varicella Virus (Chickenpox) Vaccine as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Varicella Virus (Chickenpox) Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Varicella Virus (Chickenpox) Vaccine Sales by Region (2020-2025) & (K Units)

Table 18. Global Varicella Virus (Chickenpox) Vaccine Sales Market Share by Region (2020-2025)

Table 19. Global Varicella Virus (Chickenpox) Vaccine Sales by Region (2026-2031) & (K Units)

Table 20. Global Varicella Virus (Chickenpox) Vaccine Sales Market Share by Region (2026-2031)

Table 21. Global Varicella Virus (Chickenpox) Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Varicella Virus (Chickenpox) Vaccine Revenue Market Share by Region (2020-2025)

Table 23. Global Varicella Virus (Chickenpox) Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Varicella Virus (Chickenpox) Vaccine Revenue Market Share by Region (2026-2031)

Table 25. North America Varicella Virus (Chickenpox) Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Varicella Virus (Chickenpox) Vaccine Sales by Country (2020-2025) & (K Units)

Table 27. North America Varicella Virus (Chickenpox) Vaccine Sales by Country (2026-2031) & (K Units)

Table 28. North America Varicella Virus (Chickenpox) Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Varicella Virus (Chickenpox) Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Varicella Virus (Chickenpox) Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Varicella Virus (Chickenpox) Vaccine Sales by Country (2020-2025) & (K Units)

Table 32. Europe Varicella Virus (Chickenpox) Vaccine Sales by Country (2026-2031) & (K Units)

Table 33. Europe Varicella Virus (Chickenpox) Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Varicella Virus (Chickenpox) Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Varicella Virus (Chickenpox) Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Varicella Virus (Chickenpox) Vaccine Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Varicella Virus (Chickenpox) Vaccine Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Varicella Virus (Chickenpox) Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Varicella Virus (Chickenpox) Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Varicella Virus (Chickenpox) Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Varicella Virus (Chickenpox) Vaccine Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Varicella Virus (Chickenpox) Vaccine Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Varicella Virus (Chickenpox) Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Varicella Virus (Chickenpox) Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Varicella Virus (Chickenpox) Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Varicella Virus (Chickenpox) Vaccine Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Varicella Virus (Chickenpox) Vaccine Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Varicella Virus (Chickenpox) Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Varicella Virus (Chickenpox) Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Varicella Virus (Chickenpox) Vaccine Sales (K Units) by Type (2020-2025)

Table 51. Global Varicella Virus (Chickenpox) Vaccine Sales (K Units) by Type (2026-2031)

Table 52. Global Varicella Virus (Chickenpox) Vaccine Sales Market Share by Type (2020-2025)

Table 53. Global Varicella Virus (Chickenpox) Vaccine Sales Market Share by Type (2026-2031)

Table 54. Global Varicella Virus (Chickenpox) Vaccine Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Varicella Virus (Chickenpox) Vaccine Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Varicella Virus (Chickenpox) Vaccine Revenue Market Share by Type (2020-2025)

Table 57. Global Varicella Virus (Chickenpox) Vaccine Revenue Market Share by Type (2026-2031)

Table 58. Global Varicella Virus (Chickenpox) Vaccine Price (USD/Unit) by Type (2020-2025)

Table 59. Global Varicella Virus (Chickenpox) Vaccine Price (USD/Unit) by Type (2026-2031)

Table 60. Global Varicella Virus (Chickenpox) Vaccine Sales (K Units) by User (2020-2025)

Table 61. Global Varicella Virus (Chickenpox) Vaccine Sales (K Units) by User (2026-2031)

Table 62. Global Varicella Virus (Chickenpox) Vaccine Sales Market Share by User (2020-2025)

Table 63. Global Varicella Virus (Chickenpox) Vaccine Sales Market Share by User (2026-2031)

Table 64. Global Varicella Virus (Chickenpox) Vaccine Revenue (US$ Million) by User (2020-2025)

Table 65. Global Varicella Virus (Chickenpox) Vaccine Revenue (US$ Million) by User (2026-2031)

Table 66. Global Varicella Virus (Chickenpox) Vaccine Revenue Market Share by User (2020-2025)

Table 67. Global Varicella Virus (Chickenpox) Vaccine Revenue Market Share by User (2026-2031)

Table 68. Global Varicella Virus (Chickenpox) Vaccine Price (USD/Unit) by User (2020-2025)

Table 69. Global Varicella Virus (Chickenpox) Vaccine Price (USD/Unit) by User (2026-2031)

Table 70. GSK Company Information

Table 71. GSK Description and Business Overview

Table 72. GSK Varicella Virus (Chickenpox) Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. GSK Varicella Virus (Chickenpox) Vaccine Product

Table 74. GSK Recent Developments/Updates

Table 75. Merck & Co. Company Information

Table 76. Merck & Co. Description and Business Overview

Table 77. Merck & Co. Varicella Virus (Chickenpox) Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Merck & Co. Varicella Virus (Chickenpox) Vaccine Product

Table 79. Merck & Co. Recent Developments/Updates

Table 80. Sanofi Pasteur Company Information

Table 81. Sanofi Pasteur Description and Business Overview

Table 82. Sanofi Pasteur Varicella Virus (Chickenpox) Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Sanofi Pasteur Varicella Virus (Chickenpox) Vaccine Product

Table 84. Sanofi Pasteur Recent Developments/Updates

Table 85. Green Cross Company Information

Table 86. Green Cross Description and Business Overview

Table 87. Green Cross Varicella Virus (Chickenpox) Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Green Cross Varicella Virus (Chickenpox) Vaccine Product

Table 89. Green Cross Recent Developments/Updates

Table 90. Shanghai Institute Company Information

Table 91. Shanghai Institute Description and Business Overview

Table 92. Shanghai Institute Varicella Virus (Chickenpox) Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Shanghai Institute Varicella Virus (Chickenpox) Vaccine Product

Table 94. Shanghai Institute Recent Developments/Updates

Table 95. BCHT Company Information

Table 96. BCHT Description and Business Overview

Table 97. BCHT Varicella Virus (Chickenpox) Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. BCHT Varicella Virus (Chickenpox) Vaccine Product

Table 99. BCHT Recent Developments/Updates

Table 100. Changsheng Company Information

Table 101. Changsheng Description and Business Overview

Table 102. Changsheng Varicella Virus (Chickenpox) Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Changsheng Varicella Virus (Chickenpox) Vaccine Product

Table 104. Changsheng Recent Developments/Updates

Table 105. Keygen Company Information

Table 106. Keygen Description and Business Overview

Table 107. Keygen Varicella Virus (Chickenpox) Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Keygen Varicella Virus (Chickenpox) Vaccine Product

Table 109. Keygen Recent Developments/Updates

Table 110. Biken Company Information

Table 111. Biken Description and Business Overview

Table 112. Biken Varicella Virus (Chickenpox) Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Biken Varicella Virus (Chickenpox) Vaccine Product

Table 114. Biken Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Varicella Virus (Chickenpox) Vaccine Distributors List

Table 118. Varicella Virus (Chickenpox) Vaccine Customers List

Table 119. Varicella Virus (Chickenpox) Vaccine Market Trends

Table 120. Varicella Virus (Chickenpox) Vaccine Market Drivers

Table 121. Varicella Virus (Chickenpox) Vaccine Market Challenges

Table 122. Varicella Virus (Chickenpox) Vaccine Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of Varicella Virus (Chickenpox) Vaccine

Figure 2. Global Varicella Virus (Chickenpox) Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Varicella Virus (Chickenpox) Vaccine Market Share by Type: 2024 & 2031

Figure 4. Monovalent Vaccine Product Picture

Figure 5. Combination Vaccine Product Picture

Figure 6. Global Varicella Virus (Chickenpox) Vaccine Market Value by User (2020-2031) & (US$ Million)

Figure 7. Global Varicella Virus (Chickenpox) Vaccine Market Share by User: 2024 & 2031

Figure 8. Children

Figure 9. Teenagers

Figure 10. Adults

Figure 11. Global Varicella Virus (Chickenpox) Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Varicella Virus (Chickenpox) Vaccine Market Size (2020-2031) & (US$ Million)

Figure 13. Global Varicella Virus (Chickenpox) Vaccine Sales (2020-2031) & (K Units)

Figure 14. Global Varicella Virus (Chickenpox) Vaccine Average Price (USD/Unit) & (2020-2031)

Figure 15. Varicella Virus (Chickenpox) Vaccine Report Years Considered

Figure 16. Varicella Virus (Chickenpox) Vaccine Sales Share by Manufacturers in 2024

Figure 17. Global Varicella Virus (Chickenpox) Vaccine Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Varicella Virus (Chickenpox) Vaccine Players: Market Share by Revenue in Varicella Virus (Chickenpox) Vaccine in 2024

Figure 19. Varicella Virus (Chickenpox) Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Varicella Virus (Chickenpox) Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Varicella Virus (Chickenpox) Vaccine Sales Market Share by Country (2020-2031)

Figure 22. North America Varicella Virus (Chickenpox) Vaccine Revenue Market Share by Country (2020-2031)

Figure 23. U.S. Varicella Virus (Chickenpox) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Varicella Virus (Chickenpox) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Varicella Virus (Chickenpox) Vaccine Sales Market Share by Country (2020-2031)

Figure 26. Europe Varicella Virus (Chickenpox) Vaccine Revenue Market Share by Country (2020-2031)

Figure 27. Germany Varicella Virus (Chickenpox) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Varicella Virus (Chickenpox) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Varicella Virus (Chickenpox) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Varicella Virus (Chickenpox) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Varicella Virus (Chickenpox) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Varicella Virus (Chickenpox) Vaccine Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Varicella Virus (Chickenpox) Vaccine Revenue Market Share by Region (2020-2031)

Figure 34. China Varicella Virus (Chickenpox) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Varicella Virus (Chickenpox) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Varicella Virus (Chickenpox) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Varicella Virus (Chickenpox) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Varicella Virus (Chickenpox) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Taiwan Varicella Virus (Chickenpox) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Indonesia Varicella Virus (Chickenpox) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Thailand Varicella Virus (Chickenpox) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Malaysia Varicella Virus (Chickenpox) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Philippines Varicella Virus (Chickenpox) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Latin America Varicella Virus (Chickenpox) Vaccine Sales Market Share by Country (2020-2031)

Figure 45. Latin America Varicella Virus (Chickenpox) Vaccine Revenue Market Share by Country (2020-2031)

Figure 46. Mexico Varicella Virus (Chickenpox) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Brazil Varicella Virus (Chickenpox) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Argentina Varicella Virus (Chickenpox) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Middle East and Africa Varicella Virus (Chickenpox) Vaccine Sales Market Share by Country (2020-2031)

Figure 50. Middle East and Africa Varicella Virus (Chickenpox) Vaccine Revenue Market Share by Country (2020-2031)

Figure 51. Turkey Varicella Virus (Chickenpox) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Saudi Arabia Varicella Virus (Chickenpox) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. U.A.E Varicella Virus (Chickenpox) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Global Sales Market Share of Varicella Virus (Chickenpox) Vaccine by Type (2020-2031)

Figure 55. Global Revenue Market Share of Varicella Virus (Chickenpox) Vaccine by Type (2020-2031)

Figure 56. Global Varicella Virus (Chickenpox) Vaccine Price (USD/Unit) by Type (2020-2031)

Figure 57. Global Sales Market Share of Varicella Virus (Chickenpox) Vaccine by User (2020-2031)

Figure 58. Global Revenue Market Share of Varicella Virus (Chickenpox) Vaccine by User (2020-2031)

Figure 59. Global Varicella Virus (Chickenpox) Vaccine Price (USD/Unit) by User (2020-2031)

Figure 60. Varicella Virus (Chickenpox) Vaccine Value Chain

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions